Quibim

Quibim is a health technology company that develops artificial intelligence-driven solutions for medical imaging, aiming to turn imaging data into actionable insights for healthcare providers and life sciences. The company designs software as a medical device (SaMD) and cloud-based platforms, such as QP-Insights, that process multi-modality images from MRI, CT, and PET scans. By utilizing advanced radiomics and deep learning techniques, Quibim creates tools that automate segmentation, provide quantitative measurements, and standardize imaging data. Its product portfolio includes specific applications like QP-Prostate for cancer detection, QP-Brain for neurological analysis, and QP-Liver for managing metabolic conditions, all of which are designed to integrate seamlessly into existing clinical workflows and PACS environments.

These solutions are intended to improve diagnostic accuracy, support clinical decision-making, and streamline workloads for radiologists. Beyond clinical practice, Quibim partners with biopharmaceutical companies and research organizations to accelerate drug development, patient stratification, and the generation of real-world evidence by correlating imaging biomarkers with clinical data. Headquartered in Spain, the company has secured significant venture funding to support its international expansion, particularly in the United States, and maintains a focus on building foundational AI models to move toward precision medicine and comprehensive digital health monitoring.